Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Board Appointment

4 Sep 2017 07:00

RNS Number : 6139P
Ideagen PLC
04 September 2017
 

4 September 2017

Ideagen plc

 

("Ideagen" or the "Company")

 

Board Appointment

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, is pleased to announce the appointment of Tony Rodriguez to its board of directors as a non-executive director with immediate effect.

Mr Rodriguez, aged 48, is an experienced technology entrepreneur and software developer. After an early career in a number of blue-chip technology companies, he founded Avellino Technologies Ltd in 1997, and personally led the development of its data profiling software product, now known as TS Discovery, before its acquisition in 2004 by Harte Hanks Trillium. Subsequently he founded X88 Software, since acquired by Experian in 2014, where he led, as CEO and CTO, the development of its data management product (now known as Experian Pandora), which was recognised as a visionary by Gartner.

Jonathan Wearing, Chairman, commented that:

"We are delighted that Tony has agreed to join the Board. He brings to Ideagen a wealth of experience in successfully developing and commercialising market-leading software, which will be extremely helpful as we continue to drive forward the growth of the business."

Further information, as required pursuant to Schedule 2(g) of the AIM Rules for Companies, are set out below.

Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

X88 Limited

X88 Software Limited

Tony Rodriguez Limited

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Enquiries:

Ideagen plc

Tel: 01629 699100

David Hornsby, Chief Executive

Graeme Spenceley, Finance Director

finnCap (Nominated Adviser and Broker)

Tel: 020 7220 0500

Stuart Andrews / James Thompson (Corporate Finance)

Stephen Norcross (Corporate Broking)

 

About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUQGBUPMGPG
Date   Source Headline
25th Jun 20147:00 amRNSAcquisition of EIBS Ltd
5th Jun 20142:06 pmRNSHolding(s) in Company
3rd Jun 20147:00 amRNSIssue of ordinary shares
16th May 20147:00 amRNSIssue of ordinary shares
7th May 20147:00 amRNSTrading Update and Further NHS Contract Wins
17th Mar 20147:00 amRNSNHS Contract Wins
4th Mar 20147:00 amRNSContract Wins and Trading Update
20th Jan 201411:54 amRNSHolding(s) in Company
14th Jan 20147:00 amRNSHalf Yearly Report
3rd Jan 20144:41 pmRNSSecond Price Monitoring Extn
3rd Jan 20144:35 pmRNSPrice Monitoring Extension
17th Dec 20137:00 amRNSNotice of Results
20th Nov 20137:00 amRNSAcquisition of Pentana Ltd
6th Nov 20137:00 amRNSTrading update
30th Oct 201312:22 pmRNSAnnual Report & Accounts
29th Oct 20132:38 pmRNSResult of AGM
16th Oct 201312:02 pmRNSHolding(s) in Company
8th Oct 20137:00 amRNSIssue of ordinary shares
7th Oct 20137:00 amRNSNotice of AGM
9th Sep 20137:00 amRNSFurther Healthcare Contract Wins
16th Jul 20137:01 amRNSFinal Results
16th Jul 20137:00 amRNSNew Contract Win worth £300k
9th Jul 20137:00 amRNSNotice of Results
3rd Jul 20137:00 amRNSAcquisition of MSS Management Systems Services Ltd
10th Jun 20137:00 amRNSStrategic Partnership
10th May 20131:15 pmRNSDirector/PDMR Shareholding
10th May 20137:00 amRNSVA Contract Update
7th May 20137:00 amRNSTrading Update
22nd Apr 20137:00 amRNSContract Wins and Trading Update
19th Mar 20132:39 pmRNSHolding(s) in Company
12th Mar 20137:00 amRNSContract Wins and Board Change
31st Jan 20137:00 amRNSIssue of Equity and Award of Options
22nd Jan 20137:00 amRNSHalf Yearly Report
16th Jan 20137:00 amRNSHealthcare Contract Wins and New Appointments
16th Jan 20137:00 amRNSHolding(s) in Company
10th Jan 20137:00 amRNSNotice of Results
7th Jan 201312:55 pmRNSResult of General Meeting and Issue of Equity
24th Dec 20121:07 pmRNSHolding(s) in Company
24th Dec 201212:21 pmRNSHolding(s) in Company
19th Dec 20123:00 pmRNSPosting of Circular and Notice of General Meeting
17th Dec 20127:00 amRNSPlacing and acquisition
29th Nov 20127:00 amRNSTrading Update
9th Nov 20124:16 pmRNSHolding(s) in Company
31st Oct 20121:40 pmRNSResult of AGM
10th Oct 20125:57 pmRNSHolding(s) in Company
8th Oct 201211:42 amRNSNotice of AGM and Change of Address
3rd Sep 20128:25 amRNSHolding(s) in Company
29th Aug 20127:00 amRNSHolding(s) in Company
29th Aug 20127:00 amRNSContract Win
24th Jul 20127:00 amRNSPreliminary Results 30 April 2012

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.